Substituted imidazoline reactions with chloroacetate salts
AssigneeStepan Chemical Company
InventorsJoseph R. Wechsler, Thomas G. Baker, George T. Battaglini, Frank L. Skradski
Life of this patent
Estimating the term…
Abstract
A process is provided for making amphoteric surfactant compositions from substituted imidazolines whereby such substituted imidazolines are reacted with chloroacetate salts and then hydrolyzed to open the imidazoline ring and produce a solution which is substantially completely free from cyclic groups. The product solutions are highly foamable and have low skin irritation and low eye irritation characteristics.
Claims11
A process for making an amphoteric surfactant composition having low skin irritation and low eye irritation characteristics comprising the steps of
- (A) first heating an agitated mixture comprised of
- (1) at least one substantially pure compound of the formula:
- ##STR5## where:
- R is an aliphatic radical containing from about 5 to 19 carbon atoms per molecule, and
- n is a positive whole number of from 2 to 4, inclusive,
- (2) at least one chloroacetate salt wherein the cationic portion thereof is selected from the group consisting of alkali metal, ions, and
- (3) water
- said mixture containing the equivalent of from about 1.0 to 2.5 moles of said chloroacetate salt for each mole of said formula compound, and further containing a quantity of water such that said mixture comprises from about 20 to 50 weight percent solids on a 100 weight percent total said mixture basis, said first heating being conducted at a temperature ranging from about 70.degree. to 80.degree. l C. for a time sufficient to substantially completely consume said chloroacetate salt,
- (B) mixing with the resulting reactant mixture from about 1 to 2.5 moles, corresponding to the equivalent molar amount of chloroacetate salt added to said reactant mixture in step A of at least one base selected from the group consisting of alkali metal hydroxides, and then
- (C) secondly heating the resulting reactant mixture at a temperature of from about 70.degree. to 80.degree. C. at least until substantially all of the imidazoline rings present in said resulting reactant mixture have opened, thereby forming a clear aqueous solution of from about 15 to 35 weight percent linear amphoteric compounds on a 100 weight percent total solution basis.
Dependencies are inferred from the claim text.